Studies have suggested that Nrf2 inhibits NLRP3 inflammasome activation via regulating Trx1/TXNIP complex [16, 20], thereby making Nrf2-TXNIP-Trx signaling a potential mechanism that links neuroinflammation and oxidative stress to MDD susceptibility. This evidence concerns the gene NLRP3 and major depressive disorder.